Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lineage Cell Therapeutics (LCTX) Other Accumulated Expenses (2016 - 2023)

Lineage Cell Therapeutics' Other Accumulated Expenses history spans 13 years, with the latest figure at $1000.0 for Q2 2023.

  • For Q2 2023, Other Accumulated Expenses fell 90.0% year-over-year to $1000.0; the TTM value through Jun 2023 reached $1000.0, down 90.0%, while the annual FY2021 figure was $178000.0, 1877.78% up from the prior year.
  • Other Accumulated Expenses reached $1000.0 in Q2 2023 per LCTX's latest filing, down from $37000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $492000.0 in Q2 2021 to a low of $1000.0 in Q2 2023.
  • Average Other Accumulated Expenses over 5 years is $78187.5, with a median of $31000.0 recorded in 2022.
  • Peak YoY movement for Other Accumulated Expenses: skyrocketed 1877.78% in 2021, then tumbled 97.97% in 2022.
  • A 5-year view of Other Accumulated Expenses shows it stood at $4000.0 in 2019, then surged by 125.0% to $9000.0 in 2020, then surged by 1877.78% to $178000.0 in 2021, then tumbled by 85.96% to $25000.0 in 2022, then tumbled by 96.0% to $1000.0 in 2023.
  • Per Business Quant, the three most recent readings for LCTX's Other Accumulated Expenses are $1000.0 (Q2 2023), $37000.0 (Q1 2023), and $25000.0 (Q3 2022).